GET /api/v0.1/hansard/entries/1130213/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 1130213,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1130213/?format=api",
    "text_counter": 52,
    "type": "speech",
    "speaker_name": "Hon. Uhuru Kenyatta",
    "speaker_title": "His Excellency the President",
    "speaker": {
        "id": 168,
        "legal_name": "Uhuru Muigai Kenyatta",
        "slug": "uhuru-kenyatta"
    },
    "content": "In 2020 alone, Revital exported over 70 million COVID-19 vaccine syringes to over 20 countries globally. In fact, Revital currently has the capacity to produce 300 million COVID vaccine syringes every year. The global shortage for COVID-19 vaccine syringes stands at two billion and this itself is taking advantage of opportunity. This means Revital is able to produce one out of every 10 COVID-19 vaccine syringes globally. The company saw opportunity in the crisis of COVID-19, adapted accordingly and innovated its business processes to optimise on the new opportunity. Another company in the same league is Hela, a global apparel making company with a foothold in Kenya. In the first months of the pandemic, this company changed its strategy from producing clothes to producing Personal Protective Equipment (PPE) and facemasks. With the World Health Organisation (WHO) requirements of 80 million facemasks per month at the height of the COVID-19 duress, Hela produced five million masks a month between April and May 2020. This means, through innovation, Hela manufactured one out of 16 masks required globally per month thus contributing immensely to the slowing down of the COVID-19 pandemic. This, again, was a case of seeing opportunity in a disaster and adapting to the changes. However, choices are nothing without leadership. I say so because when COVID-19 hit our country, my Administration found itself confronted with a dilemma of two rights. Opinion was sharply divided on whether to lockdown the country or to leave it open. On one side of the divide, they presented an economic argument. They advised us to leave the country open and save the economy. They argued that COVID-19 was a health crisis that should not trump economic imperatives. The other side of the divide made a compelling health argument against the economic argument. Led by a brain trust of medical scientists and researchers, they argued that the country had no option but to lockdown. Their models pointed to a soaring crisis if drastic"
}